Though it has similar effects, IGF-1 LR3 does not adhere to IGF binding proteins as strongly as IGF-1
The pathway to Irish availability would typically include: Completion of Phase 3 trials Submission to regulatory authorities European Medicines Agency review Authorisation National reimbursement and supply decisions Even under favourable timelines, widespread availability in Ireland is unlikely in the immediate future
In one sentence: Microdose semaglutide refers to using weekly doses below the lowest FDA-approved starting dose of 0.25 mg, typically 0.05 to 0.2 mg per week, with no consensus clinical definition and no randomized controlled trial testing a true microdose as a primary endpoint
Recommended dose: Take 1-2 capsules daily, whole, with a meal and plenty of liquid
Individual results will vary based on health status, age, and lifestyle.